Bristol-Myers Squibb (HIV R&D assets) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Bristol-Myers Squibb (HIV R&D assets) General Information

Description

Development of HIV medicines. The unit engages in the research and development of HIV medicines and performing pre-clinical trials and set discovery phases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 345 Park Avenue
  • New York, NY 10154
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bristol-Myers Squibb (HIV R&D assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.

Request a free trial

Bristol-Myers Squibb (HIV R&D assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.

Request a free trial